Mortality in schizophrenia: a measurable clinical endpoint
نویسندگان
چکیده
Over the last five years, large data sets on mortality in schizophrenia have been published which have established mortality as a measurable clinical endpoint. Four issues need clarification: whether mortality rates are declining, what the causes of death are, the effects antipsychotic treatments have on mortality and whether these data inform as to how mortality may be reduced in the future. A PubMed search was carried out to identify relevant publications. The search strategy was conducted as a review focusing predominantly on data since 2006. A large number of retrospective epidemiological and prospective studies have been published on mortality rates and causation in schizophrenia, predominantly from 2006-2009. Data suggest that the mortality gap with the general population increased from the 1970s but may have peaked in the mid-1990s. The main causes of mortality are suicide, cancer and cardiovascular disease, with evidence that cancer mortality rates are similar to cardiovascular mortality rates. Mortality causation is dependent upon age of the cohort, length of follow up and type of study. Antipsychotic treatments reduce mortality when compared with no treatment and atypical antipsychotics do not appear to increase cardiovascular mortality and morbidity compared with conventionals; further research is required for any definitive conclusion.
منابع مشابه
Ultrasonographic Assessment of Caudal Vena Cava to Aorta Ratio as a Novel Endpoint in Hemorrhagic Shock Resuscitation in Dogs
Objective- The aim of this study was to assess ultrasonography-derived caudal vena cava to aorta ratio (CVC/Ao) as a novel endpoint in the resuscitation of experimental hemorrhagic shock in dogs. Design- Experimental study. Animals- Ten adult mongrel healthy dogs. Procedures- After induction of anesthesia (con...
متن کاملTreatment-Responsiveness of Negative Symptoms in Schizophrenia: A double-blind placebo-control clinical trial
Background: The negative symptoms of schizophrenia remain a major clinical challenge. Nortriptyline is a serotonin and noradrenalin reuptake inhibitor and belongs to secondary amine tricycles. The aim of this study is to evaluate the effect of nortriptyline on the negative symptoms of schizophrenia. Methods: This study is a six-week randomized placebo-control trial of nortriptyline or placebo a...
متن کاملVertebral Heart Score: A Useful Parameter in Determination of Resuscitation Endpoint in Dogs with Hemorrhagic Shock
BACKGROUND: GReliable prediction of patient response to fluid resuscitation is a crucial issue in the management of hemorrhagic shock. OBJECTIVES: This study was designed to investigate vertebral heart score (VHS) variation in fluid resuscitation of hemorrhagic shock patients and the feasibility of this method in determining resuscitation endpoint. METHODS: VHS values were assessed using previ...
متن کاملProtective Role of Obsessive-Compulsive Symptoms in Schizophrenia
Objective: The relationship between obsessive compulsive disorder and schizophrenia has been a matter of dispute for ages. This study aimed to investigate the differences between schizophrenia with obsessive compulsive symptoms (OCS) and schizophrenia without OCS in affecting positive and negative symptoms of schizophrenia. Methods: Study participants comprised 30 patients with schizophr...
متن کاملP7: The Prevalence of Social Anxiety in Inpatients with Schizophrenia
Social anxiety is a frequent, disabling condition but often unrecognized feature in schizophrenia. The aim of this study was to describe the prevalence of social anxiety among inpatients with schizophrenia. Sixty inpatients with DSM-V schizophrenia were recruited from Niayesh psychiatric hospital in 2015 in Tehran, Iran. They were interviewed with the Anxiety Disorders section of the SCID for D...
متن کامل